Zhinan Xia

Company: Abimmune

Job title: Founder,President & Chief Scientific Officer

Seminars:

Roundtable Discussion: Taking Learnings from CAR-T Therapies & Moving On to T-Cell Engagers in Autoimmunity to Leverage Improved Safety, Efficacy, & Reduced CRS 5:00 pm

Translating precision targeting from CAR-T to TCEs for safer autoimmune therapies. Exploring how the antigen specificity and conditional activation lessons from CAR-Ts can be applied to TCE design to minimize off-target effects and reduce immunerelated toxicities in non-malignant settings Designing TCEs to mimic CAR-T persistence by discussing strategies to optimize TCE half-life and tissue distribution…Read more

day: Day One